|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 401 to 500 out of 1180 for Flt3

0.03s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
GXD Expression
Probe: MGI:4886105
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757723
Pattern: Regionally restricted
Stage: TS23
Assay Id: MGI:4945920
Age: embryonic day 15.5
Image: g01965 E15.5
Note: Expression was region specific and scattered.
Specimen Label: g01965 E15.5
Detected: true
Specimen Num: 1
GXD Expression
Probe: MGI:4886105
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:1757728
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:4945920
Age: postnatal day 7
Image: g01965 P7
Note: Expression was region specific and scattered.
Specimen Label: g01965 P7
Detected: true
Specimen Num: 2
GXD Expression
Probe: MGI:4886105
Assay Type: RNA in situ
Annotation Date: 2011-04-11
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1757728
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:4945920
Age: postnatal day 42
Image: g01965 Adult
Note: Expression was region specific and scattered.
Specimen Label: g01965 Adult
Detected: true
Specimen Num: 3
GXD Expression      
Probe: MGI:6457438
Assay Type: RNA in situ
Annotation Date: 2020-12-29
Strength: Absent
Sex: Not Specified
Emaps: EMAPS:1757723
Stage: TS23
Assay Id: MGI:6488549
Age: embryonic day 15.5
Specimen Label: S1 Table B14
Detected: false
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3521728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: Table 1
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3521728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: 3F
Detected: true
Specimen Num: 6
GXD Expression    
Probe: MGI:6403261
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3521728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403263
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403262
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Strong
Sex: Not Specified
Emaps: EMAPS:3521728
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403265
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3554628
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: Table 1
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6403261
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3554628
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403263
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403262
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3554628
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403265
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3561128
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: 3A
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3561128
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: Table 1
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6403261
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3561128
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403263
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403262
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3561128
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403265
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Present
Sex: Not Specified
Emaps: EMAPS:3676928
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: 3D
Detected: true
Specimen Num: 4
GXD Expression  
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3677428
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Note: Expression is in the periventricular nucleus.
Specimen Label: Table 1
Detected: true
Specimen Num: 7
GXD Expression  
Probe: MGI:6403261
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3677428
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6403263
Age: postnatal adult
Note: Expression is in the periventricular nucleus.
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression  
Probe: MGI:6403262
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Weak
Sex: Not Specified
Emaps: EMAPS:3677428
Pattern: Regionally restricted
Stage: TS28
Assay Id: MGI:6403265
Age: postnatal adult
Note: Expression is in the periventricular nucleus.
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3763328
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: Table 1
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6403261
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3763328
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403263
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403262
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3763328
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403265
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403226
Assay Type: RNA in situ
Annotation Date: 2020-04-07
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3781928
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403229
Age: postnatal adult
Specimen Label: Table 1
Detected: true
Specimen Num: 7
GXD Expression    
Probe: MGI:6403261
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3781928
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403263
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
GXD Expression    
Probe: MGI:6403262
Assay Type: RNA in situ
Annotation Date: 2020-04-08
Strength: Moderate
Sex: Not Specified
Emaps: EMAPS:3781928
Pattern: Not Specified
Stage: TS28
Assay Id: MGI:6403265
Age: postnatal adult
Specimen Label: Not shown
Detected: true
Specimen Num: 1
UniProt Feature
Begin: 28
Description: Receptor-type tyrosine-protein kinase FLT3
Type: chain
End: 1000
Publication      
First Author: Han X
Year: 2021
Journal: Cell Stem Cell
Title: A suite of new Dre recombinase drivers markedly expands the ability to perform intersectional genetic targeting.
Publication
First Author: Vekariya U
Year: 2023
Journal: Blood
Title: DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.
Volume: 141
Issue: 19
Pages: 2372-2389
Publication
First Author: Hannum C
Year: 1994
Journal: Nature
Title: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs.
Volume: 368
Issue: 6472
Pages: 643-8
Publication
First Author: Lyman SD
Year: 1993
Journal: Cell
Title: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells.
Volume: 75
Issue: 6
Pages: 1157-67
Publication
First Author: Yin N
Year: 2012
Journal: J Immunol
Title: Functional specialization of islet dendritic cell subsets.
Volume: 188
Issue: 10
Pages: 4921-30
Publication
First Author: Li Y
Year: 2020
Journal: Cell Stem Cell
Title: Single-Cell Analysis of Neonatal HSC Ontogeny Reveals Gradual and Uncoordinated Transcriptional Reprogramming that Begins before Birth.
Volume: 27
Issue: 5
Pages: 732-747.e7
Publication
First Author: Droho S
Year: 2021
Journal: Sci Rep
Title: Dendritic cells play no significant role in the laser-induced choroidal neovascularization model.
Volume: 11
Issue: 1
Pages: 17254
Publication
First Author: Svensson MN
Year: 2016
Journal: J Leukoc Biol
Title: Impaired signaling through the Fms-like tyrosine kinase 3 receptor increases osteoclast formation and bone damage in arthritis.
Volume: 99
Issue: 3
Pages: 413-23
Publication
First Author: Pronier E
Year: 2018
Journal: Blood
Title: Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis.
Volume: 132
Issue: 12
Pages: 1265-1278
Publication
First Author: Mupo A
Year: 2013
Journal: Leukemia
Title: A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.
Volume: 27
Issue: 9
Pages: 1917-20
Publication
First Author: Scheller M
Year: 2021
Journal: Nat Cancer
Title: Hotspot DNMT3A mutations in clonal hematopoiesis and acute myeloid leukemia sensitize cells to azacytidine via viral mimicry response.
Volume: 2
Issue: 5
Pages: 527-544
Publication
First Author: Brunetti L
Year: 2018
Journal: Cancer Cell
Title: Mutant NPM1 Maintains the Leukemic State through HOX Expression.
Volume: 34
Issue: 3
Pages: 499-512.e9
Publication
First Author: Velasco-Hernandez T
Year: 2015
Journal: Leukemia
Title: Loss of HIF-1α accelerates murine FLT-3(ITD)-induced myeloproliferative neoplasia.
Volume: 29
Issue: 12
Pages: 2366-74
Publication
First Author: Demircan MB
Year: 2022
Journal: J Cancer Res Clin Oncol
Title: Context-specific effects of NOX4 inactivation in acute myeloid leukemia (AML).
Volume: 148
Issue: 8
Pages: 1983-1990
Publication
First Author: Zriwil A
Year: 2016
Journal: Blood
Title: Macrophage colony-stimulating factor receptor marks and regulates a fetal myeloid-primed B-cell progenitor in mice.
Volume: 128
Issue: 2
Pages: 217-26
Publication
First Author: Yang Q
Year: 2011
Journal: J Immunol
Title: Cutting edge: Natural helper cells derive from lymphoid progenitors.
Volume: 187
Issue: 11
Pages: 5505-9
Publication
First Author: Fennell KA
Year: 2022
Journal: Nature
Title: Non-genetic determinants of malignant clonal fitness at single-cell resolution.
Volume: 601
Issue: 7891
Pages: 125-131
Publication
First Author: Solovey M
Year: 2019
Journal: J Hematol Oncol
Title: Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML.
Volume: 12
Issue: 1
Pages: 72
Publication
First Author: Taylor SJ
Year: 2015
Journal: Exp Hematol
Title: Loss of c-Cbl E3 ubiquitin ligase activity enhances the development of myeloid leukemia in FLT3-ITD mutant mice.
Volume: 43
Issue: 3
Pages: 191-206.e1
Publication
First Author: Mundy-Bosse BL
Year: 2016
Journal: J Clin Invest
Title: MicroRNA-29b mediates altered innate immune development in acute leukemia.
Volume: 126
Issue: 12
Pages: 4404-4416
Publication
First Author: Wang H
Year: 2020
Journal: Leukemia
Title: Targeting cell membrane HDM2: A novel therapeutic approach for acute myeloid leukemia.
Volume: 34
Issue: 1
Pages: 75-86
Publication
First Author: Nguyen LXT
Year: 2021
Journal: Leukemia
Title: Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemia.
Volume: 35
Issue: 8
Pages: 2285-2298
Publication
First Author: Buteyn NJ
Year: 2020
Journal: J Immunol
Title: Activation of the Intracellular Pattern Recognition Receptor NOD2 Promotes Acute Myeloid Leukemia (AML) Cell Apoptosis and Provides a Survival Advantage in an Animal Model of AML.
Volume: 204
Issue: 7
Pages: 1988-1997
Publication
First Author: Hoang DH
Year: 2022
Journal: Proc Natl Acad Sci U S A
Title: MicroRNA networks in FLT3-ITD acute myeloid leukemia.
Volume: 119
Issue: 16
Pages: e2112482119
Publication
First Author: Bernot KM
Year: 2013
Journal: Leukemia
Title: Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML.
Volume: 27
Issue: 12
Pages: 2379-82
Publication
First Author: Wang Y
Year: 2014
Journal: Blood
Title: Echinomycin protects mice against relapsed acute myeloid leukemia without adverse effect on hematopoietic stem cells.
Volume: 124
Issue: 7
Pages: 1127-35
Publication
First Author: Yankova E
Year: 2021
Journal: Nature
Title: Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia.
Volume: 593
Issue: 7860
Pages: 597-601
Publication
First Author: Mallardo M
Year: 2013
Journal: Leukemia
Title: NPMc+ and FLT3_ITD mutations cooperate in inducing acute leukaemia in a novel mouse model.
Volume: 27
Issue: 11
Pages: 2248-51
Publication
First Author: Lara-Astiaso D
Year: 2023
Journal: Nat Genet
Title: In vivo screening characterizes chromatin factor functions during normal and malignant hematopoiesis.
Volume: 55
Issue: 9
Pages: 1542-1554
Publication
First Author: Pharr PN
Year: 1997
Journal: Exp Hematol
Title: Loss of flk-2/flt3 expression during commitment of multipotent mouse hematopoietic progenitor cells to the mast cell lineage.
Volume: 25
Issue: 7
Pages: 620-8
Publication
First Author: Williams JW
Year: 2020
Journal: Nat Immunol
Title: Limited proliferation capacity of aortic intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression.
Volume: 21
Issue: 10
Pages: 1194-1204
Publication
First Author: Romine KA
Year: 2023
Journal: Leukemia
Title: BET inhibitors rescue anti-PD1 resistance by enhancing TCF7 accessibility in leukemia-derived terminally exhausted CD8(+) T cells.
Volume: 37
Issue: 3
Pages: 580-592
Publication
First Author: Moshofsky KB
Year: 2019
Journal: Blood Adv
Title: Acute myeloid leukemia-induced T-cell suppression can be reversed by inhibition of the MAPK pathway.
Volume: 3
Issue: 20
Pages: 3038-3051
Publication
First Author: Vu T
Year: 2020
Journal: Nat Commun
Title: Hematopoietic stem and progenitor cell-restricted Cdx2 expression induces transformation to myelodysplasia and acute leukemia.
Volume: 11
Issue: 1
Pages: 3021
Publication
First Author: Kunimoto H
Year: 2017
Journal: Blood
Title: Aid is a key regulator of myeloid/erythroid differentiation and DNA methylation in hematopoietic stem/progenitor cells.
Volume: 129
Issue: 13
Pages: 1779-1790
Publication
First Author: Liu F
Year: 1997
Journal: Blood
Title: The granulocyte colony-stimulating factor receptor is required for the mobilization of murine hematopoietic progenitors into peripheral blood by cyclophosphamide or interleukin-8 but not flt-3 ligand.
Volume: 90
Issue: 7
Pages: 2522-8
Publication
First Author: Auffray C
Year: 2009
Journal: J Exp Med
Title: CX3CR1+ CD115+ CD135+ common macrophage/DC precursors and the role of CX3CR1 in their response to inflammation.
Volume: 206
Issue: 3
Pages: 595-606
Publication
First Author: Kats LM
Year: 2014
Journal: Cell Stem Cell
Title: Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.
Volume: 14
Issue: 3
Pages: 329-41
Publication
First Author: Nabinger SC
Year: 2019
Journal: Leukemia
Title: Mutant p53 enhances leukemia-initiating cell self-renewal to promote leukemia development.
Volume: 33
Issue: 6
Pages: 1535-1539
Publication
First Author: Barbieri I
Year: 2017
Journal: Nature
Title: Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control.
Volume: 552
Issue: 7683
Pages: 126-131
Publication
First Author: Cai Z
Year: 2020
Journal: Cell Rep
Title: Targeting Bim via a lncRNA Morrbid Regulates the Survival of Preleukemic and Leukemic Cells.
Volume: 31
Issue: 12
Pages: 107816
Publication
First Author: Kazi JU
Year: 2013
Journal: Exp Hematol
Title: The presence or absence of IL-3 during long-term culture of Flt3-ITD and c-Kit-D816V expressing Ba/F3 cells influences signaling outcome.
Volume: 41
Issue: 7
Pages: 585-7
Publication
First Author: Yang M
Year: 2022
Journal: Leukemia
Title: A unique role of p53 haploinsufficiency or loss in the development of acute myeloid leukemia with FLT3-ITD mutation.
Volume: 36
Issue: 3
Pages: 675-686
Publication
First Author: Orellana EA
Year: 2021
Journal: Mol Cell
Title: METTL1-mediated m(7)G modification of Arg-TCT tRNA drives oncogenic transformation.
Volume: 81
Issue: 16
Pages: 3323-3338.e14
Publication
First Author: Lordo MR
Year: 2021
Journal: J Immunol
Title: Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor.
Volume: 207
Issue: 6
Pages: 1672-1682
Publication
First Author: Schwarz BA
Year: 2007
Journal: J Immunol
Title: Selective thymus settling regulated by cytokine and chemokine receptors.
Volume: 178
Issue: 4
Pages: 2008-17
Publication      
First Author: Labarthe L
Year: 2019
Journal: J Leukoc Biol
Title: Frontline Science: Exhaustion and senescence marker profiles on human T cells in BRGSF-A2 humanized mice resemble those in human samples.
Publication  
First Author: Flynn PA
Year: 2024
Journal: Front Immunol
Title: Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency.
Volume: 15
Pages: 1297338
Publication
First Author: Crozat K
Year: 2006
Journal: Mamm Genome
Title: Analysis of the MCMV resistome by ENU mutagenesis.
Volume: 17
Issue: 5
Pages: 398-406
Publication
First Author: Cimmino L
Year: 2017
Journal: Cell
Title: Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Volume: 170
Issue: 6
Pages: 1079-1095.e20
Publication
First Author: Varol C
Year: 2009
Journal: Immunity
Title: Intestinal lamina propria dendritic cell subsets have different origin and functions.
Volume: 31
Issue: 3
Pages: 502-12
Publication
First Author: Jiao J
Year: 2014
Journal: J Immunol
Title: Central role of conventional dendritic cells in regulation of bone marrow release and survival of neutrophils.
Volume: 192
Issue: 7
Pages: 3374-82
Publication
First Author: Billiard F
Year: 2012
Journal: J Exp Med
Title: Dll4-Notch signaling in Flt3-independent dendritic cell development and autoimmunity in mice.
Volume: 209
Issue: 5
Pages: 1011-28
Publication
First Author: Darrasse-Jèze G
Year: 2009
Journal: J Exp Med
Title: Feedback control of regulatory T cell homeostasis by dendritic cells in vivo.
Volume: 206
Issue: 9
Pages: 1853-62
Publication
First Author: Nakano H
Year: 2013
Journal: Mucosal Immunol
Title: Migratory properties of pulmonary dendritic cells are determined by their developmental lineage.
Volume: 6
Issue: 4
Pages: 678-91
Publication
First Author: Kunimoto H
Year: 2018
Journal: Cancer Cell
Title: Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity.
Volume: 33
Issue: 1
Pages: 44-59.e8
Publication
First Author: Meyer SE
Year: 2016
Journal: Cancer Discov
Title: DNMT3A Haploinsufficiency Transforms FLT3ITD Myeloproliferative Disease into a Rapid, Spontaneous, and Fully Penetrant Acute Myeloid Leukemia.
Volume: 6
Issue: 5
Pages: 501-15
Publication
First Author: Muto T
Year: 2022
Journal: Cell Stem Cell
Title: TRAF6 functions as a tumor suppressor in myeloid malignancies by directly targeting MYC oncogenic activity.
Volume: 29
Issue: 2
Pages: 298-314.e9
Publication
First Author: Paubelle E
Year: 2020
Journal: Cell Rep
Title: Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.
Volume: 30
Issue: 3
Pages: 739-754.e4
Publication
First Author: Anderson NR
Year: 2023
Journal: Leukemia
Title: Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.
Volume: 37
Issue: 3
Pages: 560-570
Publication
First Author: Elf S
Year: 2011
Journal: Blood
Title: p90RSK2 is essential for FLT3-ITD- but dispensable for BCR-ABL-induced myeloid leukemia.
Volume: 117
Issue: 25
Pages: 6885-94
Publication
First Author: Tam WF
Year: 2013
Journal: Cancer Res
Title: STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2.
Volume: 73
Issue: 1
Pages: 373-84
Publication
First Author: Tsui CC
Year: 1996
Journal: J Neurosci
Title: Narp, a novel member of the pentraxin family, promotes neurite outgrowth and is dynamically regulated by neuronal activity.
Volume: 16
Issue: 8
Pages: 2463-78
Publication
First Author: Ku H
Year: 1996
Journal: Blood
Title: Soluble thrombopoietin receptor (Mpl) and granulocyte colony-stimulating factor receptor directly stimulate proliferation of primitive hematopoietic progenitors of mice in synergy with steel factor or the ligand for Flt3/Flk2.
Volume: 88
Issue: 11
Pages: 4124-31
Publication
First Author: Ueda K
Year: 2021
Journal: Cancer Cell
Title: MDMX acts as a pervasive preleukemic-to-acute myeloid leukemia transition mechanism.
Volume: 39
Issue: 4
Pages: 529-547.e7
Publication
First Author: Douam F
Year: 2018
Journal: Nat Commun
Title: Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses.
Volume: 9
Issue: 1
Pages: 5031
Publication
First Author: Yun TJ
Year: 2016
Journal: Cell Metab
Title: Indoleamine 2,3-Dioxygenase-Expressing Aortic Plasmacytoid Dendritic Cells Protect against Atherosclerosis by Induction of Regulatory T Cells.
Volume: 23
Issue: 5
Pages: 852-66
Publication
First Author: Min J
Year: 2018
Journal: Exp Mol Med
Title: Inflammation induces two types of inflammatory dendritic cells in inflamed lymph nodes.
Volume: 50
Issue: 3
Pages: e458
Publication
First Author: O'Leary HA
Year: 2017
Journal: Leukemia
Title: DPP4 truncated GM-CSF and IL-3 manifest distinct receptor-binding and regulatory functions compared with their full-length forms.
Volume: 31
Issue: 11
Pages: 2468-2478
Publication
First Author: Farache J
Year: 2013
Journal: Immunity
Title: Luminal bacteria recruit CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation.
Volume: 38
Issue: 3
Pages: 581-95
Publication
First Author: Booth CAG
Year: 2018
Journal: Cancer Cell
Title: Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.
Volume: 33
Issue: 2
Pages: 274-291.e8
Publication
First Author: Satpathy AT
Year: 2014
Journal: Blood
Title: Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder.
Volume: 123
Issue: 19
Pages: 2968-77
Publication
First Author: Du X
Year: 2004
Journal: Genetics
Title: Velvet, a dominant Egfr mutation that causes wavy hair and defective eyelid development in mice.
Volume: 166
Issue: 1
Pages: 331-40
Publication
First Author: Mohan JF
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Imaging the emergence and natural progression of spontaneous autoimmune diabetes.
Volume: 114
Issue: 37
Pages: E7776-E7785